Wird geladen...
Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review
Cytomegalovirus (CMV) is a leading opportunistic infection in immune compromised patients, including allogeneic hematopoietic stem cell (HSCT) or solid organ transplant (SOT) recipients, where primary infection or reactivation is associated with increased morbidity and mortality. Antiviral drugs are...
Gespeichert in:
| Veröffentlicht in: | Infect Drug Resist |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6556539/ https://ncbi.nlm.nih.gov/pubmed/31239725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S180908 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|